Coloplast A/S (OTCMKTS:CLPBY) Reaches New 12-Month Low – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price reached a new 52-week low on Thursday . The company traded as low as $6.10 and last traded at $6.20, with a volume of 28664 shares. The stock had previously closed at $6.38.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CLPBY shares. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. The Goldman Sachs Group downgraded Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Coloplast A/S has a consensus rating of “Hold”.

Coloplast A/S Stock Down 0.6%

The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. The stock has a market cap of $13.97 billion, a P/E ratio of 44.29, a PEG ratio of 1.97 and a beta of 0.15. The firm has a 50-day simple moving average of $6.53 and a two-hundred day simple moving average of $7.72.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. Equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.